Flavio Frohlich, PhD, associate professor, UNC Neuroscience Center, and Founder of Pulvinar Neuro, and Leah Townsend, PhD, CEO of Pulvinar Neuro
We are excited to announce a strategic partnership with Electromedical Products International, Inc. (EPI), a leading medical device company using non-invasive brain stimulation to treat psychiatric disorders. This partnership will allow us to accelerate our non-invasive brain stimulation and product development, including transcranial alternating current stimulation (tACS), individualized feedback stimulation, and cloud-enabled therapeutics for the treatment of psychiatric and neurological illnesses.
I am looking forward to working with EPI to bring the next generation of personalized non-invasive brain stimulation to market, complementary with EPI's suites of devices, which we are confident will benefit millions of patients who are looking for effective and safe treatment options.
EPI is the market leader in low-current, non-invasive brain stimulation and has a long-standing track record of marketing its patented, FDA-cleared Alpha-Stim technology for the treatment of anxiety, insomnia, depression, and pain.
Closed-loop low-intensity transcranial stimulation for the treatment of CNS disorder has a very bright future ahead.